About IP Osgoode

IP Osgoode is an independent voice that explores legal governance issues at the intersection of intellectual property (IP) and technology. The program’s researchers, collaborators, and students actively engage in some of the most important and cutting-edge IP law and technology related research and policy discussions of today.


Latest from IPilogue

Commentary and analysis on the latest developments in intellectual property, technology and privacy, featuring curated contributions from students, scholars, and experts within the Osgoode community.

Evidence Of Parasitic Intent Not Unfounded: L’Oreal

Apr 23, 2012 1 min read
dummy-img

Advocate General Mengozzi delivered his opinion to the European Union’s Court of Justice (ECJ), on February 16 2012, denying the Appeal sought by Helena Rubenstein SNC and L’Oreal SA concerning the Community trademarks BOTOLIST and BOTOCYL. Botox was registered as a word mark from 1991 to 2003 for goods in Class 5 of the Nice […]

Copyright Reform, The Irish Way

Apr 15, 2012 1 min read
dummy-img

The current copyright statute in Ireland is the Copyright & Related Rights Act 2000. It was changed (a little) to bring Irish law into line with the EU Copyright Directive (2001), but not much has happened since. But following a promise in the coalition agreement after the 2011 general election, a Copyright Review Committee (chaired […]

Patenting Health: You Cannot Own the Laws of Nature

Apr 15, 2012 1 min read
dummy-img

On March 20, 2012, the United States Supreme Court decided Mayo Collaborative Services v. Prometheus Laboratories, Inc., 132 S. Ct. 1289 (U.S. 2012). The case was unanimous and emphatically reaffirmed that United States patent law does not allow ownership of "laws of nature." The context was a pair of patents owned by Prometheus which claimed […]

Disclosure Front and Centre as Pfizer Prepares to Defend Viagra in Supreme Court of Canada

Apr 15, 2012 1 min read
dummy-img

This Wednesday, April 18, Pfizer will defend the patent protecting the little blue pill that has changed the lives of men and women around the world.  The pill is of course Viagra and the assailant is Teva, a generic pharmaceutical company.  Teva applied for a Notice of Compliance in order to market a generic version […]

Two Years to Trial, Three Years Later

Apr 11, 2012 1 min read
dummy-img

Three years ago, the Federal Court announced a plan to try to schedule trials within two years of the commencement of the proceeding. Since that time, many new patent cases have been commenced and some trials have been scheduled and heard. Has the court met its goals for patent infringement actions? In Canada, most patent […]

Bill C-11: Through the Lens of Social Norms

Apr 11, 2012 1 min read
dummy-img

The Copyright Modernization Act (Bill C-11) has generated much discussion on its merits and deficiencies. However, one issue that commentators have not discussed in depth is the relationship between laws and social norms. Specifically, whether any amendments to copyright law in Canada will have an effect on user behaviour given the social acceptability of copyright […]

Editor in Chief: Prof. Carys Craig (ccraig@osgoode.yorku.ca)
Submission inquiries: iposgoode@osgoode.yorku.ca